Identification of potential target genes associated with the reversion of androgen-dependent skeletal muscle atrophy

Arch Biochem Biophys. 2019 Mar 15:663:173-182. doi: 10.1016/j.abb.2019.01.009. Epub 2019 Jan 11.

Abstract

Muscle wasting or atrophy is extensively associated with human systemic diseases including diabetes, cancer, and kidney failure. Accumulating evidence from transcriptional profiles has noted that a common set of genes, termed atrogenes, is modulated in atrophying muscles. However, the transcriptional changes that trigger the reversion or attenuation of muscle atrophy have not been characterized at the molecular level until now. Here, we applied cDNA microarrays to investigate the transcriptional response of androgen-sensitive Levator ani muscle (LA) during atrophy reversion. Most of the differentially expressed genes behaved as atrogenes and responded to castration-induced atrophy. However, seven genes (APLN, DUSP5, IGF1, PIK3IP1, KLHL38, PI15, and MKL1) did not respond to castration but instead responded exclusively to testosterone replacement. Considering that almost all proteins encoded by these genes are associated with the reversion of atrophy and may function as regulators of cell proliferation/growth, our results provide new perspectives on the existence of anti-atrogenes.

Keywords: And atrophy reversion; Atrogenes; FBXO32; Muscle atrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens / metabolism*
  • Animals
  • Fasting
  • Gene Expression Profiling*
  • Hormone Replacement Therapy
  • Male
  • Mice
  • Models, Biological
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Muscular Atrophy / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • Orchiectomy
  • Rats
  • Rats, Wistar
  • Testosterone / administration & dosage

Substances

  • Androgens
  • Testosterone